$NXEN
Nexien Biopharma Inc Stock $nxen

2021 Q4 Form 10-Q Financial Statement

Concept	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.940K
YoY Change	-93.89%
Cash & Equivalents	$2.942K
Short-Term Investments
Other Short-Term Assets	$0.00
YoY Change	-100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.940K
YoY Change	-94.57%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$2.940K
Total Long-Term Assets	$0.00
Total Assets	$2.940K
YoY Change	-94.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.560K
YoY Change
Accrued Expenses	$35.00K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$23.80K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$65.37K
YoY Change	2312.18%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00
YoY Change	-100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$65.37K
Total Long-Term Liabilities	$0.00
Total Liabilities	$65.37K
YoY Change	115.17%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$62.43K
YoY Change
Total Liabilities & Shareholders Equity	$2.940K
YoY Change	-94.57%

Concept	2021 Q4
OPERATING ACTIVITIES
Net Income	-$220.2K
YoY Change	-73.41%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$15.75K
YoY Change	-37.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00
YoY Change
Cash From Investing Activities	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	15.00K
YoY Change	-76.92%
NET CHANGE
Cash From Operating Activities	-15.75K
Cash From Investing Activities	0.000
Cash From Financing Activities	15.00K
Net Change In Cash	-750.0
YoY Change	-101.88%
FREE CASH FLOW
Cash From Operating Activities	-$15.75K
Capital Expenditures
Free Cash Flow
YoY Change

Frame	Concept Type	Concept / XBRL Key	Unit
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	USD
CY2021Q4	NXEN	Common Stock Subject To Forfeiture CommonStockSubjectToForfeiture	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	USD
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	USD
	NXEN	Stock Issued Or Issuable To Officers StockIssuedOrIssuableToOfficers	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	USD
	us-gaap	Stock Issued1 StockIssued1	USD
	NXEN	Shares Issued For Settlement Of Accounts Payable SharesIssuedForSettlementOfAccountsPayable	USD